Active	Status	Sponsor type	Region	Phase	Filter
8 Active 2 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Letavernier, Emmanuel
NCT04147871 / 2017-002067-18: Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children	Not yet recruiting	2/3	72	Europe	ADV7103, Placebo	Advicenne Pharma	Cystinuria	05/25	06/25
Figueres, Lucile
FALCON, NCT03918447 / 2018-004651-20: A Trial of Bardoxolone Methyl in Patients With ADPKD -	Terminated	3	667	Europe, Japan, US, RoW	Bardoxolone methyl oral capsule, RTA 402, Placebo oral capsule	Reata, a wholly owned subsidiary of Biogen, Reata Pharmaceuticals, Inc., REATA PHARMACEUTICALS, INC	Autosomal Dominant Polycystic Kidney, ADPKD	08/23	08/23
XLHRegistry, NCT03193476: Registry for Patients With X-Linked Hypophosphatemia	Recruiting	N/A	1343	Europe, RoW		Kyowa Kirin Pharmaceutical Development Ltd, Iqvia Pty Ltd	X-Linked Hypophosphatemia	02/29	07/29